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Purpose: The study was performed comparing dosimetric characteristics of 
volumetric modulated arc therapy (VMAT) and field-in-field (FiF) tech-
niques on a patient with synchronous bilateral breast carcinoma. Methods: 
The patients with bilateral breast cancer treatment were included in this 
study. A total dose of 40.05 Gy in 15 fractions was prescribed to the Planning 
Target Volume (PTV) of the whole bilateral breast cancer with the supracla-
vicular and infraclavicular nodes, with a complementary boost of 10 Gy in 4 
fractions to the surgical bed (PTVboost). For both radiotherapy techniques, 
several VxGy parameters were analyzed for the PTVs, together with the Con-
formity index (CI), the Homogeneity index (HI) and the critical organs at 
risk (OARs), lungs and heart. Results: The patient was treated by the VMAT 
technique and the daily treatment time was less than 20 minutes with daily 
CBCT imaging. In the VMAT plan, the PTV 95% dose covered 38.89 ± 0.81 
Gy, compared to 37.26 ± 1.02 Gy in the FiF technique. The VMAT plan im-
proved the dose homogeneity index and lower dose in lung towards high dose 
region. Conclusion: The study demonstrates the viability of the VMAT tech-
nique in the treatment of bilateral breast cancer. The introduced single iso-
centric VMAT technique is fast to deliver and it increases the dose homo-
geneity of the target volume with some limitations. The treatment was well 
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1. Introduction 
Breast cancer is the most common cancer in women, constituting 24.2% ac-
cording to GLOBOCAN 2018 [1]. Synchronous bilateral breast cancer (BBC) is 
defined as two or more malignant tumors occurring simultaneously in both 
breasts. Synchronous bilateral breast cancer is an uncommon finding in women, 
presenting multiple breast lumps with an estimated incidence of 2.1% [2]. Bila-
teral breast cancers are classified depending on the time of occurrence into syn-
chronous (detected simultaneously or within a 6 months gap) or metachronous 
[3] (detected in an interval longer than 6 months). 
Risk factors are familial breast cancer, young age, lobular invasive carcinoma, 
multicentricity, BRCA 1 & 2 gene mutations and radiation exposure [4]. Patients 
with breast carcinoma are treated with either modified radical mastectomy or 
breast conservative surgery (BCS), followed by breast irradiation in appropriate-
ly selected women. Adjuvant radiotherapy for breast cancer is classically given 
using medial and lateral tangential fields. 
In patients diagnosed with early synchronous bilateral breast cancer, breast 
conservation therapy is feasible [5]. Planning for bilateral breast cancer radio-
therapy is a challenging task. The radiotherapy planning and dose delivery are 
more complex in bilateral breast cancer. 
The use of classical tangential fields in the treatment of bilateral breast cancer 
has many disadvantages, including significant inhomogeneity in dose distribu-
tion, high dose to critical structures and lack of conformity to planning target 
volume (PTV) even after using the field-in-field (FiF) technique [6]. These can 
lead to acute side effects, such as skin toxicity, and late effects, for instance, soft 
tissue fibrosis, pneumonitis and cardiotoxicity, which affect the quality of life. 
Modern techniques of radiation, Rapid Arc (Volumetric Modulated Arc Thera-
py—VMAT) and Intensity Modulated Radiotherapy (IMRT) have been utilized 
to overcome these problems. The purpose of this report is to share the perceived 
dosimetric benefits and drawbacks of VMAT over FiF for bilateral breast cancer 
radiotherapy. 
2. Material and Methods 
Clinical history: 
Five patients with a bilateral breast cancer, who underwent treatment with the 
VMAT technique in our institute during April 2019-August 2020, were included 
into this study. A 68-year-old patient with a bilateral breast cancer underwent 
left mastectomy and sentinel node dissection for a pT1c bifocal pN0(sn) and 
right-side lumpectomy with axillar dissection for pT2pN1a (2/12). Bilateral ra-
diotherapy was specified before the prescription of hormonal therapy. The dose 
prescription was 15 times 2.67 Gy by the START scheme to the thoracic wall and 
15 times 2.67 Gy to the left and to the right breast and regional lymph nodes 
(axillar-susclavicular level 2 to 4 and the nodes of the internal mammary chain). 
There was a boost dose prescribed to the original tumor bed of the right breast 
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of 4 times 2.5 Gy. 
Treatment simulation: 
The patients were imaged with a CT scanner (Toshiba Aquilion LB, Toshiba 
Medical Systems Co., Tochigi, Japan) in the treatment position on the breast 
board—in supine position with both hands raised above the head. CT data was 
acquired from the mandible to the 4th lumbar vertebra, with a slice thickness of 3 
mm during normal breathing. These CT images were then transferred online to 
the Eclipse (v15.4, Varian Medical Systems, Palo Alto, CA) Treatment Planning 
System (TPS). In the first step, Planning Target volumes (PTV) of (right and left 
breasts) were delineated on the CT data according to the department guidelines. 
The organs at risk (OAR) were contoured, including the heart and both lungs. 
The plans were generated by two techniques, i.e. field-in-field (FiF) and VMAT, 
to a total dose of 40.05 Gy in 15 fractions to both breast, thoracic wall and su-
praclavicular areas. 
Treatment planning: 
FiF is a radiation therapy technique that uses several less-weighted fields with 
a small treatment field size to optimize dose distributions. The initial calculation 
of the FiF plan was performed with two equally weighted, open, tangential pho-
ton beams without wedges. 
Two cm leaf margins have been added towards the skin side. Two or three 
subfields were determined for hot spot volumes blocking to improve dose ho-
mogeneity, while decreasing overdoses in the PTV. The beam weight of the sub-
field was 2% to 3% of the main field. The minimum monitor unit (MU) of each 
subfield was 8 and the main field and the subfields were merged into one portal. 
The VMAT plan was generated in the Eclipse TPS, having Acuros XB algo-
rithm, in the dose-to-medium dose reporting mode, with 2.5 mm calculation 
grid size. The plan was completed using four continuous arcs (arc length: 179˚ - 
181˚), with 6 MV photon beams on Varian Clinac iX accelerators equipped with 
a Millennium 120 multileaf collimator (MLC) (Varian Medical Systems, Palo 
Alto, CA, USA). A single isocenter placed medially under the sternum was used 
for optimization. The collimator angle was set to a value of ±15˚. For optimiza-
tion purposes, a breast PTV was defined as the combination of the left and right 
breast PTVs cropped 5 mm inwards from the skin edge. PTVs were cropped to 
achieve plan objectives without forcing the optimizer to increase skin dose ex-
cessively to compensate for the lack of scatter in this region. To create robust ra-
diotherapy planning by reducing positioning uncertainties, we used the pseudo 
skin flash method described by Giorgia [7]. 
Treatment evaluation: 
Conformity Index (CI) and Homogeneity Index (HI) are defined according to 
the ICRU 83 report. CI is defined as the ratio of the volume to 95% of the pre-
scribed dose to the PTV (CI = V95% PTV). HI is defined as the ratio of the dose 
difference of 2% and 98% to the PTV to the dose to 50% (HI = D2% − 
D98%/D50%). V95% is the percentage of volume (PTV) receiving 95% of dose. 
Quality Assurance (QA) of the treatment plan was performed on a Varian 
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EPID (Electronic Portal Imaging Devices). The differences between calculated 
and measured dose distributions were evaluated by the gamma parameter [8]. 
3. Results 
We compared the two treatment plans to determine which one would offer the 
best coverage of our target areas, while at the same time minimizing the dose to 
OARs. After comparison of both plans and weighing the pros and cons for each 
plan, it was decided to treat the patient according to the plan generated in 
VMAT. 
The patient was treated using the VMAT technique with four arcs with 6MV 
photons. For the 15 VMAT sessions, a single daily cone-beam CT (CBCT) im-
aging was performed for patient setup. Image reconstruction and automatic im-
age registration were performed. The shifts to cranio-caudal, left-right and ante-
rior-posterior directions from the daily CBCT images ranged between −0.4 to 
1.9 cm (average 2 mm), −1.2 to 0.4 cm (average 10 mm) and −0.5 to 1.2 (average 
5 mm), respectively. 
Figure 1 shows a comparison of dose distribution by FiF and VMAT tech-
niques in the axial, coronal and sagittal planes. On the left side (a) is the clinical 
FiF plan and on the right side (b) is the full arc VMAT plan in the axial, coronal 
and sagittal planes. PTV is indicated in red color for both breasts. The color 
wash represents 95% of dose prescription. The total number of monitor units 
(MU) was 1546 for the VMAT technique, while it was 910 for the FiF technique. 
The overall treatment time with daily CBCT matching was less than 20 minutes, 
with an average beam-on time of 330 s. 
Figure 2 shows the dose volume histogram for the FiF and VMAT techniques. 
The color blue, cyan, magenta and pink curves represent coverage of left lung, 
right lung, total lung and heart contours, respectively, for FiF (square line) and 
VMAT (triangle line). The PTV coverage 95% isodose line was chosen as a ref-
erence. Table 1 shows that VMAT plan has better PTV coverage, with good 
conformity index (CI) of 1.13 and homogeneity index (HI) of 0.10, when com-
pared to the FiF technique. According to the VMAT plan, the PTV 95% dose 
covered 38.89 ± 0.81 Gy, while it reached 37.26 ± 1.02 Gy by the FiF. 
The VMAT technique improved sparing of the surrounding critical structures 
in the high dose region, however FiF is superior in the low dose region. Beyond 
13 Gy, FiF delivered a higher dose, compared to VMAT, for total lung. Table 2 
presents the dosimetric parameter as a point dose and mean to OARs. 
Comparing our VMAT plan with the data reported by Kim et al., [7], the 
mean heart dose obtained for our patient was 3.22 ± 0.65 Gy, while it was 14.5 ± 
2.39 Gy in their study. In the QA verification, the gamma parameter (3%, 3 mm) 
value was 96.5% (tolerance 95%). 
Treatment planning for BBC is arduous and, in most cases, the field overlap-
ping cannot be avoided with traditional tangential field arrangements. To mi-
nimize damage to the skin, the overlapping areas with large hotspots should be  
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Figure 1. Comparison of isodose distributions seen for left and right breast with IM (internal mammary), SC (supraclavicular 
region) and AX (axillary lymph) nodes. 
 
 
Figure 2. Dose volume histogram for FiF (square line red color) and VMAT (triangle line red color) treatment plans. 
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Table 1. Dosimetric parameters for PTV for FiF and VMAT. Indicated statistical error 
uncertainty is standard deviation. 
PTV parameter FiF VMAT 
V95% Gy 37.26 ± 1.02 38.89 ± 0.81 
Dmax (Gy) 42.64 ± 0.91 42.45 ± 1.75 
Dmean (Gy) 39.40 ± 0.5 40.14 ± 0.2 
CI 1.25 ± 0.8 1.13 ± 0.4 
HI 0.26 ± 0.1 0.10 ± 0.07 
Total MU 910 ± 120 1546 ± 227 
 
Table 2. Dosimetric parameters for organs-at-risk by FiF and VMAT. Indicated statistical 
error uncertainty is standard deviation. 
OAR  FiF VMAT 
LT Lung V17Gy 6.21% ± 5.02% 8.18% ± 6.32% 
 V10Gy 8.47% ± 4.02% 24.69% ± 3.55% 
Rt Lung V17Gy 24.54% ± 1.18% 15.04% ± 2.21% 
 V10Gy 29.71% ± 3.22% 44.98% ± 4.25% 
Total Lung Dmean (Gy) 6.64 ± 2.08 10.48 ± 1.95 
Heart Dmean (Gy) 0.89 ± 0.55 3.22 ± 0.65 
 
avoided. On the other hand, the PTV area should receive the prescription dose 
without cold spots to minimize the risk of tumor recurrence. 
4. Discussion 
The overall VMAT treatment time, including patient positioning, image verifi-
cation and application of corrections/shifts and beam-on time, was 20 minutes, 
which is less than that required by the IMRT and FiF techniques. This finding is 
in agreement with the results of Seppälä [9]. 
The intrafractional motion during normal breathing was studied for breast 
cancer patients [10]. Helical Tomotherapy treatment showed increased treat-
ment duration, which may cause intrafractional uncertainties. Ricotti [10] ob-
served that the baseline deviation of the body triggered more noticeable uncer-
tainties, compared to the respiratory motion. In our study, the mean an average 
beam-on time is 330 seconds. 
Fiorentino A. [11] reported the mean total lung dose of 11.8 ± 2.3 Gy with 
VMAT, while in our plan it was 10.48 Gy. Galecki J. [12] also found the mean 
dose of 16.6 Gy to total lung with the VMAT technique. Thus, VMAT increases 
dose homogeneity in the target volume and considerably decreases the treatment 
delivery time. The drawback of the VMAT treatment of BBC is the increased low 
radiation dose volume. Although the risk of cancer recurrence among patients 
treated with radiotherapy is small [13], it cannot be neglected. The low dose vo-
lume must be considered when selecting the patients to be treated with VMAT, 
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bearing in mind the increased possibility of second cancers, especially for pa-
tients with younger age. It should also be recognized that, with the introduced 
VMAT dose delivery technique, the treatment planning complexity is increased, 
thus escalating the potential for error and thus increasing the importance of the 
quality assurance processes [14]. Several studies in the literature have compared 
the radiotherapy techniques biologically. Lee B. [15] calculated the secondary 
cancer risk of different organs after radiation treatment of breast cancer based 
on a biological model. The 3D-CRT resulted in lower radiation-induced cancer 
risk in breast radiation therapy than IMRT, but dose homogeneity of IMRT was 
better than those of 3D-CRT. 
Our study confined 0.64% volume (V25%) of the heart, while with the re-
ported Helical Tomotherapy treatment deliveries the respective volume was 15% 
[16]. A population-based case control study was conducted to assess the risk of 
ischemic heart disease for breast cancer women patients after radiotherapy [17]. 
The cardiac complications are linearly associated with the mean heart dose. In-
creasing the mean dose with 1 Gy causes an estimated 7.4% rise in the heart dis-
ease risk. 
5. Conclusion 
This study confirmed that the single isocenter VMAT technique is feasible in bi-
lateral breast cancer, achieving good radiation dose homogeneity. The PTV cov-
erage is better by VMAT. Considering the VMAT planning, the main drawback 
observed in the present analysis was a slight increase in the low dose volume to 
the lung and the heart. Our report describes the process of planning synchron-
ous BBC radiotherapy with the single isocenter VMAT technique. Overall, the 
VMAT technique increases the dose coverage and is easy to deliver. 
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